Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model.

Rutjes NW, Binnington BA, Smith CR, Maloney MD, Lingwood CA.

Kidney Int. 2002 Sep;62(3):832-45.

2.

Differential intracellular transport and binding of verotoxin 1 and verotoxin 2 to globotriaosylceramide-containing lipid assemblies.

Tam P, Mahfoud R, Nutikka A, Khine AA, Binnington B, Paroutis P, Lingwood C.

J Cell Physiol. 2008 Sep;216(3):750-63. doi: 10.1002/jcp.21456.

PMID:
18446787
3.

Structure-dependent pseudoreceptor intracellular traffic of adamantyl globotriaosyl ceramide mimics.

Saito M, Mylvaganum M, Tam P, Novak A, Binnington B, Lingwood C.

J Biol Chem. 2012 May 11;287(20):16073-87. doi: 10.1074/jbc.M111.318196. Epub 2012 Mar 14.

4.

Different binding property of verotoxin-1 and verotoxin-2 against their glycolipid receptor, globotriaosylceramide.

Itoh K, Tezuka T, Inoue K, Tada H, Suzuki T.

Tohoku J Exp Med. 2001 Dec;195(4):237-43.

6.

Toxicity and immunogenicity of a verotoxin 1 mutant with reduced globotriaosylceramide receptor binding in rabbits.

Bast DJ, Brunton JL, Karmali MA, Richardson SE.

Infect Immun. 1997 Jun;65(6):2019-28.

9.
10.
11.

Neutralizing activity of bovine colostral antibody against verotoxin derived from enterohemorrhagic Escherichia coli O157:H7 in mice.

Kuribayashi T, Seita T, Fukuyama M, Furuhata K, Honda M, Matsumoto M, Seguchi H, Yamamoto S.

J Infect Chemother. 2006 Oct;12(5):251-6. Epub 2006 Nov 6.

PMID:
17109087
12.

Effect of globotriaosyl ceramide fatty acid alpha-hydroxylation on the binding by verotoxin 1 and verotoxin 2.

Binnington B, Lingwood D, Nutikka A, Lingwood CA.

Neurochem Res. 2002 Aug;27(7-8):807-13.

PMID:
12374217
15.
16.

Two distinct binding sites for globotriaosyl ceramide on verotoxins: identification by molecular modelling and confirmation using deoxy analogues and a new glycolipid receptor for all verotoxins.

Nyholm PG, Magnusson G, Zheng Z, Norel R, Binnington-Boyd B, Lingwood CA.

Chem Biol. 1996 Apr;3(4):263-75. Erratum in: Chem Biol 1996 Jan;3(1):503.

17.

Effect of verocytotoxins (Shiga-like toxins) on human neutrophils in vitro.

Holle JU, Williams JM, Harper L, Savage CO, Taylor CM.

Pediatr Nephrol. 2005 Sep;20(9):1237-44. Epub 2005 Jun 10.

PMID:
15947986
18.

Evidence that verotoxins (Shiga-like toxins) from Escherichia coli bind to P blood group antigens of human erythrocytes in vitro.

Bitzan M, Richardson S, Huang C, Boyd B, Petric M, Karmali MA.

Infect Immun. 1994 Aug;62(8):3337-47.

19.

Tumour necrosis factor alpha is not an essential component of verotoxin 1-induced toxicity in mice.

Wolski VM, Soltyk AM, Brunton JL.

Microb Pathog. 2002 Jun;32(6):263-71.

PMID:
12137753
20.

Experimental verocytotoxemia in rabbits.

Richardson SE, Rotman TA, Jay V, Smith CR, Becker LE, Petric M, Olivieri NF, Karmali MA.

Infect Immun. 1992 Oct;60(10):4154-67.

Supplemental Content

Support Center